Industry Leaders Push For “Disruptive Innovation” At Biovision
This article was originally published in The Pink Sheet Daily
Executive Summary
EU stakeholders see “disruptive innovation” in life sciences as a means of exiting the sector’s economic crisis. While pharma says that process comes at a high price, other players see it as a means of cutting costs.